NCT03430388View on ClinicalTrials.gov

Yellow Fever Vaccine in Patients With Rheumatic Diseases

NACompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

January 31, 2018

Primary Completion Date

March 24, 2018

Study Completion Date

February 24, 2019

Conditions
Systemic LupusRheumatoid ArthritisSpondyloarthritisInflammatory MyopathySystemic SclerosisMixed Connective Tissue DiseaseTakayasu ArteritisGranulomatosis With PolyangiitisSjogren's SyndromeJuvenile Idiopathic ArthritisJuvenile Dermatomyositis
Interventions
BIOLOGICAL

Yellow Fever vaccine (17D)

Vaccination against Yellow Fever, fractional dose (0,1mL) of 17D vaccine

Trial Locations (1)

05403-000

Rheumatology Division of Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo, São Paulo

All Listed Sponsors
lead

University of Sao Paulo General Hospital

OTHER

NCT03430388 - Yellow Fever Vaccine in Patients With Rheumatic Diseases | Biotech Hunter | Biotech Hunter